Status:
COMPLETED
Intensive Glycemic Management and Outcomes Following Liver Transplantation
Lead Sponsor:
Mayo Clinic
Conditions:
Hospital Hyperglycemia
Post-transplant Hyperglycemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Most people develop high blood sugars following liver transplant that requires treatment with insulin in the hospital, even if they don't have diabetes, due to stress and use of steroid medications. H...
Eligibility Criteria
Inclusion
- 18 years of age and older
- Undergoing liver transplant or combined liver-kidney transplant
Exclusion
- Unable to grant informed consent or comply with study procedure
- Allergic to any of the excipients in insulin
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT01432093
Start Date
October 1 2011
End Date
July 1 2013
Last Update
November 13 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Jacksonville, Florida, United States, 32224